Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

ONTY $1.90 0.1700 +9.83%
AGIO $72.90 4.6500 +6.81%
NWBO $5.09 0.2500 +5.17%
GALE $1.92 0.0900 +4.92%
MYGN $36.68 1.6800 +4.80%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CVM $0.69 -0.1619 -19.05%
IMGN $8.84 -0.6200 -6.55%
INO $11.55 -0.6400 -5.25%
APRI $1.56 -0.0800 -4.88%
CERU $4.30 -0.1900 -4.23%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next > | Last >>

Acadiana Colon Cancer Rates Among Nation’s Highest, Report Says

(The Advocate [Baton Rouge, LA]) Oct 12, 2014 - Colorectal cancer rates in the Acadiana region are among the nation’s highest, a health issue possibly linked to the region’s Cajun heritage, according to a study by the LSU Health New Orleans School of Public Health.
read article 



New Molecular Markers for Prostate Cancer Identified

(Sanford-Burnham Science Blog) Oct 9, 2014 - A team of scientists led by Sanford-Burnham’s Ranjan J Perera, Ph.D., has identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients, but not in normal healthy individuals.
read article 



Hormone Loss May be Involved in Colon Cancer, Study Says

(FoxNews.com) Oct 10, 2014 - Gene replacement therapy could hold promise in treating colon cancer, reveals a study published Friday in the journal Cancer, Epidemiology, Biomarkers & Prevention.
read article 



Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review

(Pfizer) Oct 13, 2014 - Pfizer Inc. today announced the New Drug Application (NDA) for palbociclib has been accepted for filing and granted Priority Review by the United States Food and Drug Administration (FDA).
read corporate press release 



CARs Motor Through Leukemia, Can 'Eradicate' Disease

(Medscape Medical News) Oct 13, 2014 - The remarkable results in leukemia patients treated with chimeric antigen receptor (CAR)-modified T-cells, which have caused such excitement among specialists treating hematologic malignancies, are now being published.
read article (free registration required) 



Got Insurance? You Still May Pay A Steep Price For Prescriptions

(Kaiser Health News) Oct 13, 2014 - Sandra Grooms recently got a call from her oncologist’s office. The chemotherapy drugs he wanted to use on her metastatic breast cancer were covered by her health plan, with one catch: Her share of the cost would be $976 for each 14-day supply of the two pills.
read article 



Doctors' Pay for Unapproved Prostate Cancer Device Raises Ethical Questions

(SFGate.com) Oct 12, 2014 - SonaCare Medical believes its treatment for prostate cancer is unusually precise and powerful, but the therapy faces a major obstacle: It is not approved in the United States.
read article 



NBC News Looks Into Possible Link Between Artificial Turf and Cancer

(Forbes) Oct 10, 2014 - NBC’s Nightly News aired scathing reports Wednesday and Thursday suggesting that artificial turf may cause cancer.
read article 



FDA Should Play Key Role in Lower Drug Costs

(The Hill/Congress blog) Oct 10, 2014 - Some big drug makers – protective of their profits – are fighting tooth and nail to roll back a provision of the ACA so that these drugs remain astronomically expensive – and inaccessible.
read article 



Big Data, Meet Big Money: NIH Funds Centers to Crunch Health Data

(Los Angeles Times) Oct 9, 2014 - Calling the world's wealth of health data a formidable "engine of discovery," the National Institutes of Health on Thursday awarded $32 million in grants in a bid to make huge biomedical data sets accessible to researchers the world over.
read article (free registration required) 



Pharma Sues Again Over Orphan Drug Discounts to Hospitals

(Wall Street Journal/Pharmalot blog) Oct 9, 2014 - An ongoing feud between the pharmaceutical industry and a federal agency over a discount drug program for certain hospitals is back in court.
read article (paid subscription required) 



“Fracking For the Cure”? Susan G. Komen Gets It All Wrong, Again

(SFGate.com/Notes & Errata blog) Oct 10, 2014 - Here’s a question: Is the Susan G. Komen breast cancer foundation insane?
read article 



PinnacleHealth Cancer Institute Expands Hematology/Oncology Program

(PinnacleHealth) Oct 9, 2014 - PinnacleHealth Cancer Institute welcomes three hematology/oncology specialists-- Irina Veytsman, MD, Jongming Li, PhD, MD and Sabrina Martyr, MD.
read press release 



5 Key Tips for Financial Advocates

(ACCCBuzz) Oct 10, 2014 - ACCCBuzz is in San Diego this week for the ACCC 31st National Oncology Conference.
read article 



Looking Back: 20 Years of Colorectal Cancer Treatment Breakthroughs Improve Survival, Advance Evidence-Based Choices

(NCCN) Oct 9, 2014 - The National Comprehensive Cancer Network® (NCCN®) has published the 20th annual editions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Colon and Rectal Cancers, two of the eight original NCCN Guidelines® published in November 1996.
read press release 



Oxford Biomedica Strikes 'Transformational' $90m Deal With Novartis

(The Telegraph [UK]) Oct 10, 2014 - Swiss drug giant extends tie-up with British biotech for experimental cancer immunotherapy programme.
read article 



EU Agency Backs Continued Use of Ariad Leukaemia Drug

(Reuters) Oct 10, 2014 - European regulators said on Friday the benefits of Ariad Pharmaceuticals' leukaemia medicine Iclusig continued to outweigh its risks, but called for strengthened warnings on the product.
read article 



Medicare Recommends $500 Reimbursement For Exact Sciences' Colon Cancer Test

(TheStreet) Oct 10, 2014 - Medicare officials are recommending a $502 reimbursement for Exact Sciences' Cologuard colon cancer screening test, according to a preliminary payment report issued Thursday night.
read article 



Panobinostat FDA Review on Schedule, Novartis Says

(The Myeloma Beacon) Oct 9, 2014 - It seems that panobinostat’s review by the U.S. Food and Drug Ad­min­is­tra­tion (FDA) may be on track after all.
read article 



The Silenced Breast Cancer Speaks Up

(Medscape Medical News) Oct 9, 2014 - Mention of deadly metastatic breast cancer is drowned out, even actively suppressed, during Pinktober, but now patients are joining together to speak up, and one woman has some blistering words.
read article (free registration required) 



MDxHealth's ConfirmMDx Genes Identify Prostate Cancer Aggressiveness in Diagnostic Biopsies

(CNBC) Oct 10, 2014 - MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, today announced positive data from an important study confirming the ability of the ConfirmMDx® genes to identify prostate cancer (PCa) aggressiveness in diagnostic biopsies.
read article 



Ipsen Announces Positive Results From Phase III Clinical Study of Decapeptyl® (triptorelin pamoate) 11.25 mg Administered by Subcutaneous Route to Prostate Cancer Patients

(Yahoo! Finance) Oct 10, 2014 - Ipsen today announced positive results from the phase III study of triptorelin pamoate 11.25 mg (Decapeptyl® 3 months) administered subcutaneously in patients with locally advanced or metastatic prostate cancer at the European Association of Urology (EAU) 14th Central European Meeting in Cracow, Poland (10-12 October 2014).
read article 



Unusual Skin Cancer Linked to Chronic Allergy From Metal Orthopedic Implant

(WUSTL) Oct 9, 2014 - In rare cases, patients with allergies to metals develop persistent skin rashes after metal devices are implanted near the skin.
read article 



Elevated Cholesterol and Triglycerides May Increase the Risk For Prostate Cancer Recurrence

(AACR) Oct 10, 2014 - Higher levels of total cholesterol and triglycerides, two types of fat, in the blood of men who underwent surgery for prostate cancer, were associated with increased risk for disease recurrence, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
read press release 



Single-Agent Cyclophosphamide For GVHD Prophylaxis

(Medscape Medical News) Oct 9, 2014 - Could a single drug replace the cocktail that is currently used to prevent graft vs host disease (GVHD) after stem cell transplantation?
read article (free registration required)